$RUN

Abajian Danny sold $27K of RUN

Abajian Danny (Chief Financial Officer) sold 2,030 shares of Sunrun Inc. (RUN) at $13.39 on 2026-06-08.

Original reporting
SEC EDGAR · Abajian Danny
Published Jun 9, 2026, 10:33 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 9, 2026, 10:35 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$RUN
Neutral
medium confidence
Mentioned
$RUN
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$RUNNeutralLow
01

Why it matters

The disclosure updates the insider activity record but does not provide new operational, financial, or regulatory information about Sunrun.

02

Market read

Traders may monitor insider activity for sentiment, but this specific sale is unlikely to drive a fundamental repricing on its own.

03

What to watch

Transaction size is small relative to typical institutional flows; without accompanying company-specific news, the signal-to-noise for trading is low.

Relevance 3/10Novelty 6/10Timing: Filed 2026-06-09; sale executed 2026-06-08

Background

This is a primary-source SEC Form 4 insider transaction disclosure for Sunrun Inc.

Company-level read

Ticker impact

$RUNNeutralMedium confidence
Context

Sunrun CFO Abajian Danny filed an open-market sale of 2,030 shares at $13.3939 on 2026-06-08 (Form 4).

Expected impact

Low near-term impact; any effect is likely sentiment-only and should be weighed against normal insider-sale patterns.

Evidence & confidence

The filing is a small, open-market sale by an officer with no 10b5-1 plan stated; however, the transaction size ($27.2K) is modest and not a corporate action or guidance/regulatory event.

Market effects

Minimal; single-company insider sale does not materially change solar/renewables sector risk.

None indicated.

None indicated.

Counterpoint

The absence of a stated 10b5-1 plan could reflect personal liquidity needs rather than bearish expectations; insider sales are often non-informational.

Key entities

  • Sunrun Inc.

    Subject of the Form 4 insider transaction disclosure (RUN).

  • Abajian Danny

    Chief Financial Officer who sold 2,030 shares in an open-market transaction.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$FSLRMed

First Solar Climbs 4% as Truist Buy Call and December Tariff Floor Reset Panel Pricing Outlook; Enphase Energy and Sunrun Hold Flat

First Solar (FSLR) stock rose 4% to $186.21 after a Truist upgrade to Buy with a $270 price target, citing improved pricing and valuation. The U.S. Department of Commerce's Section 232 trade decision sets a minimum import price for foreign solar panels, benefiting First Solar. Enphase (ENPH) and Sunrun (RUN) stocks remained flat. First Solar's thin-film technology and U.S. manufacturing position it favorably against competitors.

$RUNHigh

Goldman Sachs Cut Its Sunrun Target. It Still Sees [44%] Upside

Goldman Sachs and Citi reduced their price targets for Sunrun (RUN) to $11 and $14, respectively, while maintaining Buy ratings. Analysts anticipate a decline in Sunrun's EPS from $1.71 in 2025 to $1.00 by 2027. Sunrun's stock closed at $7.61 on Oct. 7, a 52-week low. The cuts reflect lower expectations for near-term growth and cash generation.

$RUNMed

Why is Sunrun stock sliding today?

Sunrun (RUN) stock fell 2.0% to $7.46 in pre-market trading, continuing a downtrend after price target cuts from Goldman Sachs and Citi, citing lower near-term growth expectations. The stock hit a 52-week low of $7.42, down 62% over the past year. Analysts maintained Buy ratings but reduced targets to $11 and $14, respectively. A large options trade suggests hedging against further downside. The broader market decline and policy uncertainty also weighed on the stock.